查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球静脉曲张治疗市场——行业规模.份额.趋势.机会.预测.按类型.按成分.按最终用户.按地区.竞争对手分析 (2018-2028)
市场调查报告书
商品编码
1244138

全球静脉曲张治疗市场——行业规模.份额.趋势.机会.预测.按类型.按成分.按最终用户.按地区.竞争对手分析 (2018-2028)

Varicose Veins Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type, By Component, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球静脉曲张治疗市场预计在 2024-2028 年的预测期内以稳定的复合年增长率增长。

这是由于先进的静脉曲张治疗设备的兴起推动了市场增长。 此外，对微创治疗的日益偏好预计将推动全球静脉曲张治疗市场的增长。 此外，先进的静脉曲张治疗设备的可用性预计将进一步支持市场增长。 此外，医疗设备的技术进步和现代化以及医疗领域研发活动的增加将为预测期内的静脉曲张治疗市场带来更多新机遇。 相反，扩大研究和开发以及患者和医疗保健专业人员对静脉曲张治疗的认识不断提高，有望在未来创造有利可图的机会。 慢性静脉功能不全 (CVI) 通常影响下肢，女性患病率为 25-40%，男性为 10-20%。 女性年发病率为 2% 至 6%，男性为 1.9%。

静脉疾病患病率上升

意识的提高和静脉曲张患病率的上升随后推动了市场的增长。 各种政府和非政府组织正在努力提高人们对静脉疾病的认识，并提高对其治疗的先进疗法的可用性。 例如在美国，美国血管外科医师协会和美国静脉论坛最近发表了关于静脉曲张诊断的临床治疗建议。 仅在美国，每年约有 3000 万人患有静脉曲张，而其中只有 10% 的人接受治疗。 肥胖.长时间站立工作和吸烟是静脉曲张发展的主要危险因素。 此外，据观察，在怀孕期间，由于妊娠期子宫增大，出现高血压和下肢静脉肿胀，以及因荷尔蒙分泌增多而使静脉壁变弱，诊断为静脉曲张。静脉。 静脉曲张在老年人中很常见，预计老年人口的增加将提振市场。 据估计，41% 的 50 岁以上女性患有静脉曲张。 据估计，美国 50 岁以上的人口中有 50% 患有静脉曲张。 与瘦女性相比，中度肥胖女性 (BMI 25-29.9) 患静脉曲张的风险增加 50%。

技术进步

预计全球市场将受到静脉曲张治疗设备的持续进步和静脉曲张疾病发病率增加的推动。 通过施加轻微压力来改善血液循环的加压装置的使用在静脉曲张的治疗中越来越受欢迎。 此外，由于激光治疗具有30分钟无痛治疗.低復发风险.微创和恢復快等多种优势，预计将有助于下肢静脉曲张治疗市场的增长。 根据职业安全与健康研究所的数据，全球静脉曲张的患病率在 10% 到 30% 之间变化。 此外，在预测期内，医疗设备的技术改进和现代化增加了医疗行业的研发力度。 此外，新兴地区的增长将很快为静脉曲张治疗市场创造有利可图的增长机会。

市场细分

参与企业

Alma Lasers Limited.Medtronic Plc..Boston Scientific Corporation (Lumenis Corporation).Sciton, Inc..Merit Medical Systems, Inc..BTG International Limited.Energist Limited.Teleflex Incorporated.AngioDynamics, Inc..El.En SpA集团（Quanta System）是全球静脉曲张治疗市场的主要参与者之一。

报告范围

本报告将全球静脉曲张治疗市场分为以下几类，以及下面详述的行业趋势：

静脉曲张治疗市场，按类型：

  • 静脉内消融
  • 硬化疗法
  • 手术结扎
  • 剥离

静脉曲张治疗市场，按成分分类：

  • 消融设备
  • 射频消融设备
  • 激光烧蚀装置
  • 静脉闭合产品
  • 其他

最终用户的静脉曲张治疗市场：

  • 医院和诊所
  • 门诊中心
  • 其他

静脉曲张治疗市场，按地区：

  • 北美
    • 美国
    • 墨西哥
    • 加拿大
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋

竞争格局

公司概况：对全球静脉曲张治疗市场主要参与者的深入分析。

可自定义：

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素.挑战和趋势概述

第 4 章 VOC（客户之声）

第 5 章静脉曲张治疗的全球市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型（静脉消融.硬化疗法.手术结扎/去角质）
    • 按组件（消融设备.射频消融设备.激光消融设备.静脉闭合产品等）
    • 按最终用户（医院/诊所.门诊诊所.其他）
    • 按地区
    • 按公司分类（2022 年）
  • 市场地图
    • 按类型
    • 按组件
    • 最终用户
    • 按地区

第 6 章北美静脉曲张治疗市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型
    • 按组件
    • 最终用户
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲静脉曲张治疗市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型
    • 按组件
    • 最终用户
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章亚太地区静脉曲张治疗市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型
    • 按组件
    • 最终用户
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章南美静脉曲张治疗市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型
    • 按组件
    • 最终用户
    • 按国家
  • 南美洲：：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章中东和非洲的静脉曲张治疗市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型
    • 按组件
    • 最终用户
    • 按国家
  • MEA：国家分析
    • 在南非治疗静脉曲张
    • 沙特下肢静脉曲张治疗药
    • 阿联酋下肢静脉曲张治疗

第 11 章市场动态

  • 司机
  • 做

第12章市场趋势与发展

  • 近期趋势
  • 併购
  • 产品发布

第13章竞争格局

  • 业务概览
  • 企业概况
  • 产品服务
  • 财务信息（公开数据）
  • 最新趋势
  • SWOT 分析
    • Alma Lasers Limited
    • Medtronic Plc.
    • Boston Scientific Corporation（Lumenis Corporation）
    • Sciton, Inc
    • Merit Medical Systems, Inc.
    • BTG International Limited
    • Energist Limited
    • Teleflex Incorporated
    • AngioDynamics, Inc.
    • El. En SpA Group（Quanta System）

第14章 战略建议

简介目录
Product Code: 14580

Global Varicose Veins Treatment Market is anticipated to witness growth of steady CAGR in the forecast period, 2024-2028. It can be ascribed to the rising advanced varicose vein treatment devices escalating the market growth. Besides, surging preference for minimally invasive treatment procedures is expected to drive the growth of global varicose vein treatment market. Additionally, the availability of advanced varicose vein treatment devices is further expected to support market growth. Moreover, the rise in technological advancements and modernization in healthcare devices, and the rise in the research and development activities in the healthcare sector will further create new opportunities for the varicose vein treatment market in the forecasted period. On the contrary, growing R&D and a rise in awareness among healthcare professionals as well as patients regarding varicose vein treatment are expected to create lucrative opportunities in the future. Chronic Venous Insufficiency (CVI) commonly affects lower limbs with a prevalence ranging between 25-40% and 10-20% in women and men, respectively. The annual incidence is 2-6% in women and 1.9% in men.

Rising Prevalence of Venous Disorders

Increasing awareness and the rising prevalence of varicose veins are subsequently boosting market growth. Various governmental and non-governmental organizations are taking initiatives to create awareness about venous diseases and the availability of advanced therapies for their treatment. For instance, in the U.S., recently, the Society for Vascular Surgery and the American Venous Forum issued recommendations for the diagnosis of varicose veins for clinical care. In the U.S. alone, about 30 million people are suffering from varicose veins every year, out of which, only 10% of the people seek treatment. Obesity, particularly among women, prolonged standing hours at work, and smoking, are some of the significant risk factors associated with the development of varicose veins. Additionally, varicose veins are observed to be diagnosed during pregnancies due to the enlargement of the gravid uterus, which results in hypertension and distension in the lower-extremity veins and an increase in hormone secretion, leading to the weakening of the venous walls. The varicose vein is most prevalent in the geriatric population, moreover, rising in the geriatric population is anticipated to boost the market. It is estimated that 41% of women over the age of 50 have varicose veins. It is estimated that 50% of the US population over 50 years old has varicose veins. Women who are moderately overweight (BMI 25-29.9) have a 50% increased risk of developing varicose veins compared to women who are not overweight.

Technological Advancements

The global market is likely to be driven by continuous advancements in varicose veins treatment devices and an increase in the incidence of varicose veins illness. The use of a compression device to treat varicose veins has grown in popularity because it improves blood circulation by applying mild pressure. In addition, various advantages of Laser treatment, such as a painless 30-minute procedure, minimal risk of reoccurrence, minimum invasion, quick recovery, etc., are predicted to help the growth of the Varicose Veins Treatment Market over the projection year. According to the Occupational Safety and Health Research Institute, the prevalence of lower limb varicose veins varies between 10% and 30% globally. Furthermore, in the forecasted period, technical improvements and modernization in healthcare devices increased research and development efforts in the healthcare sector. Increased growth in emerging regions will generate lucrative growth opportunities for the Varicose Veins Treatment Market shortly.

Market Segmentation

The Global Varicose Veins Treatment market is segmented based on type, component, end user, and region. Based on type, the market can be segmented into Endovenous Ablation, Sclerotherapy, Surgical Ligation, and Stripping. Based on components, the market can be differentiated into Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, and Others. Based on end users, the market can be differentiated into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, Europe dominated the market among Asia Pacific, North America, Middle East & Africa, and South America. In terms of country, among United States, North American region is dominating the overall globe in the varicose vein treatment market. Approximately 23% of US adults have varicose veins. If spider telangiectasias and reticular veins are also considered, the prevalence increases to 80% of men and 85% of women.

Market Players

Alma Lasers Limited, Medtronic Plc., Boston Scientific Corporation (Lumenis Corporation), Sciton, Inc., Merit Medical Systems, Inc., BTG International Limited, Energist Limited, Teleflex Incorporated, AngioDynamics, Inc., El. En SpA Group (Quanta System), is some of the leading players operating in the Global Varicose Veins Treatment Market.

Report Scope:

In this report, Global Varicose Veins Treatment market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Varicose Veins Treatment Market, By Type:

  • Endovenous Ablation
  • Sclerotherapy
  • Surgical Ligation
  • Stripping

Varicose Veins Treatment Market, By Component:

  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Laser Ablation Devices
  • Venous Closure Products
  • Others

Varicose Veins Treatment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Varicose Veins Treatment Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Varicose Veins Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Varicose Veins Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation & Stripping)
    • 5.2.2. By Component (Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Component
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Varicose Veins Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Component
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Varicose Veins Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End User
    • 6.3.2. Mexico Varicose Veins Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End User
    • 6.3.3. Canada Varicose Veins Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End User

7. Europe Varicose Veins Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Component
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Varicose Veins Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Varicose Veins Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Varicose Veins Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Varicose Veins Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Varicose Veins Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End User

8. Asia-Pacific Varicose Veins Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Varicose Veins Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End User
    • 8.3.2. India Varicose Veins Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Varicose Veins Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Varicose Veins Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Varicose Veins Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End User

9. South America Varicose Veins Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Varicose Veins Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Varicose Veins Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Varicose Veins Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End User

10. Middle East and Africa Varicose Veins Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Varicose Veins Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Varicose Veins Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Varicose Veins Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (As reported)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. Alma Lasers Limited
    • 13.6.2. Medtronic Plc.
    • 13.6.3. Boston Scientific Corporation (Lumenis Corporation)
    • 13.6.4. Sciton, Inc
    • 13.6.5. Merit Medical Systems, Inc.
    • 13.6.6. BTG International Limited
    • 13.6.7. Energist Limited
    • 13.6.8. Teleflex Incorporated
    • 13.6.9. AngioDynamics, Inc.
    • 13.6.10. El. En SpA Group (Quanta System)

14. Strategic Recommendations